The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease

The University of Oxford and Selvita, one of the largest contract research organizations in Europe, announced an integrated drug discovery collaboration in the area of Parkinson’s disease.

Scroll to Top